Yuvraj_pawp, Author at Pharma Advancement

Boehringer Ingelheim 3rd-generation EGFR TKI, BI 1482694, receives FDA Breakthrough Therapy Designation in lung cancer

21st December 2015

• New data from Phase I/II clinical trial presented at ESMO Asia 2015 Congress showcase the potential for BI 1482694*...

Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors

by Yuvraj_pawp

19th November 2015

Clinical Trials to Evaluate Merck’s KEYTRUDA® (pembrolizumab) in Combination with Other Medicines and Treatments Across Multiple Tumor Types Merck (NYSE:MRK),...

Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus

by Yuvraj_pawp

19th November 2015

Daktari Diagnostics today announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop Daktari’s...

Merck and Samsung Bioepis Announce Approval of BRENZYS™ (Etanercept), a Biosimilar of Enbrel, in Korea

by Yuvraj_pawp

19th November 2015

First Product from Global Partnership to Deliver High-Quality Biosimilars to Help Meet Needs of Patients and Healthcare Systems Worldwide Merck...

Syndax and Merck Announce First Patients Dosed in Phase 1b/2 Clinical Trial of Entinostat and KEYTRUDA®

by Yuvraj_pawp

19th November 2015

Clinical trial to assess safety and efficacy of immuno-oncology combination in patients with advanced NSCLC or melanoma Syndax Pharmaceuticals,...

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer

by Yuvraj_pawp

19th November 2015

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and DNAtrix today announced they have entered into an...

International Institute for Integrative Sleep Medicine (WPI-IIIS, University of Tsukuba, Japan) announces drug discovery collaboration agreement with Merck

by Yuvraj_pawp

19th November 2015

International Institute for Integrative Sleep Medicine, University of Tsukuba (“WPI-IIIS”) today announced a research collaboration agreement with Merck & Co.,...

Proteros signs new oncology collaboration with Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA on epigenetic target

by Yuvraj_pawp

19th November 2015

Proteros to receive upfront and research funding plus milestone payments of up to $126 million plus royalties Proteros biostructures GmbH...

Bionomics Announces Extension of Strategic Collaboration with Merck & Co., Inc. for the Discovery and Development of Novel Pain Medications

by Yuvraj_pawp

19th November 2015

Merck & Co., Inc. to make US$9 million investment in Bionomics Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a biopharmaceutical company focused on...

Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma

by Yuvraj_pawp

19th November 2015

Pivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma...

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Yuvraj_pawp

Boehringer Ingelheim 3rd-generation EGFR TKI, BI 1482694, receives FDA Breakthrough Therapy Designation in lung cancer

Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors

Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus

Merck and Samsung Bioepis Announce Approval of BRENZYS™ (Etanercept), a Biosimilar of Enbrel, in Korea

Syndax and Merck Announce First Patients Dosed in Phase 1b/2 Clinical Trial of Entinostat and KEYTRUDA®

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer

International Institute for Integrative Sleep Medicine (WPI-IIIS, University of Tsukuba, Japan) announces drug discovery collaboration agreement with Merck

Proteros signs new oncology collaboration with Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA on epigenetic target

Bionomics Announces Extension of Strategic Collaboration with Merck & Co., Inc. for the Discovery and Development of Novel Pain Medications

Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password